Dieser Abschnitt ist nur in englischer Sprache verfügbar.

11Equity

The share capital amounts to CHF 342’623.70, made up of 34’262’370 shares with dividend entitlement and a par value of CHF 0.01. All shares are fully paid in and registered.

Treasury shares

The total number of treasury shares held by Sulzer Ltd as of June 30, 2022, was 400’330 shares (December 31, 2021: 534’073 shares).

The treasury shares are mainly held for the purpose of issuing shares under the management share-based payment programs.

Dividends

On April 6, 2022, the Annual General Meeting approved an ordinary dividend of CHF 3.50 (2021: ordinary dividend of CHF 4.00) per share to be paid out of reserves. The dividend was paid to shareholders on April 12, 2022. The total amount of the dividend to shareholders of Sulzer Ltd was CHF 118.7 million (2021: CHF 135.4 million), thereof paid dividends of CHF 80.6 million (2021: CHF 91.9 million) and unpaid dividends of CHF 38.1 million (2021: CHF 43.5 million). The unpaid dividends are reflected in the balance sheet position “Other current and accrued liabilitiesˮ (see note 14).

Contribution from medmix

The contribution relates to vested shares under Sulzer share plans for medmix employees. 

Transaction costs recorded in equity

Transaction costs directly attributable to the spin-off of medmix are recorded as a deduction from equity.